Our insights

New issue
Autumn Issue Thirty Six
The JM Finn Quarterly Periodical

We met the companies below and you can learn more on any of these by contacting the person at JM Finn with whom you usually deal.

You will undoubtedly have heard Moderna’s name in recent months as a developer of one of the vaccines for COVID-19.

As part of our focus on providing a high quality, personalised investment service, we look to support our investment managers in their decision making when it comes to constructing client portfolios.

We were delighted to win the award for best App / Portal of the year at the 2021 Brand Management & Reputation Awards, from Citywealth.

The Affordable Art Fair is back and we are delighted to be sponsoring it again.

Imperial Brands (IMB) is a multinational nicotine (née tobacco) company. They are the fourth largest nicotine company globally, and their largest markets are the USA and Germany. The Tobacco & Next…

As we start moving our default working location from home to the office, albeit with a greater measure of flexibility, there is a shared sense of excitement across our London based staff for our new…

James Godrich reviews some of the stocks in his funds.

Is the FTSE 100 a good investment? Brian Tora explores some of its complications below.

Investment Director, London

Is the October effect just a superstition or does it carry any merit? Brian Tora provides his insight on what we can expect over the coming weeks.

Carole Annett of Country & Town House magazine offers simple, practical ideas to turn your home into a castle

Inflation affects all aspects of the economy. Read below to find out what inflation looks like at the moment and what we can potentially expect in the coming months.

In this article, fund manager James Godrich provides the insight on the current financial markets and reviews some of the recent activity in the CSI funds.